ArticleThe Journal of urology2018
Re: Randomized Phase III Trial of Adjuvant Pazopanib versus Placebo after Nephrectomy in Patients with Localized or Locally Advanced Renal Cell Carcinoma.
M Pilar LagunaPubMed ↗Publisher ↗
No numbers read from the abstract.